Skip to content
naulon
Not checkedNot checked for notices yet.

suPAR, a Circulating Kidney Disease Factor

Changli Wei, Ryan Spear, Eunsil Hahm and 1 more

Frontiers in Medicine · 2021

doi:10.3389/fmed.2021.745838 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Urokinase plasminogen activator receptor (uPAR) is a multifaceted, GPI-anchored three-domain protein. Release of the receptor results in variable levels of soluble uPAR (suPAR) in the blood circulation. suPAR levels have been linked to many disease states. In this mini-review, we discuss suPAR as a key circulating molecule mediating kidney disease with a particular focus on differently spliced isoforms.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.